POSTER: CLL-563 Bexobrutideg (NX-5948), a Novel Bruton’s Tyrosine Kinase Degrader, Demonstrates Rapid and Durable Clinical Responses in Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Findings From an Ongoing Phase 1a StudyZulfa Omer, Talha Munir, Prioty Islam et al.|Clinical Lymphoma Myeloma & Leukemia|2025Cited by 0